ConductScience.org, home

Paper39119697

Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies.

Chen BM and 8 others. ACS Nano, 2024. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies. Papers, record 39119697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39119697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies.
PubMed
Journal
ACS Nano
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
3.35, provisional
iCite
Revised in PubMed
2025-04-25
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen BMBing-Mae
2Chen EEven
3Lin YCYi-Chen
4Tran TTMTrieu Thi My
5Turjeman KKeren
6Yang SHShih-Hung
7Cheng TLTian-Luhttps://orcid.org/0000-0001-6424-4731
8Barenholz YYechezkel
9Roffler SRSteve Rhttps://orcid.org/0000-0003-2543-7295

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Polyethylene GlycolsMajor topic
LiposomesMajor topic
DoxorubicinMajor topic
Animals
Rats
Antibodies
Complement Activation
Phosphatidylethanolamines
Drug Liberation

Source PubMed

Download CSV of topics

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127369864Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.J Control Release2016https://conductscience.org/library/papers/27369864PubMed
24177022Fixation of C' and C'la by rabbit gamma-G- and gamma-M-antibodies with particulate and soluble antigens.J Immunol1968https://conductscience.org/library/papers/4177022PubMed
336641121Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture.J Control Release2023https://conductscience.org/library/papers/36641121PubMed
46609269Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.Kidney Int1983https://conductscience.org/library/papers/6609269PubMed
524626930Complement is activated by IgG hexamers assembled at the cell surface.Science2014https://conductscience.org/library/papers/24626930PubMed
633444669Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice.J Control Release2021https://conductscience.org/library/papers/33444669PubMed
730366815Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials.EBioMedicine2018https://conductscience.org/library/papers/30366815PubMed
836549393Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine).J Control Release2023https://conductscience.org/library/papers/36549393PubMed
927522158Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.J Allergy Clin Immunol2016https://conductscience.org/library/papers/27522158PubMed
1031348638Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.ACS Nano2019https://conductscience.org/library/papers/31348638PubMed
1110837758Lipid vesicles and membrane fusion.Adv Drug Deliv Rev1999https://conductscience.org/library/papers/10837758PubMed
1220536171Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies.Bioconjug Chem2010https://conductscience.org/library/papers/20536171PubMed
1315921973Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer.Chem Phys Lipids2005https://conductscience.org/library/papers/15921973PubMed
1430023837Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance.ACS Omega2018https://conductscience.org/library/papers/30023837PubMed
1512739982Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.Clin Pharmacokinet2003https://conductscience.org/library/papers/12739982PubMed
1615202568PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles.Eur J Cell Biol2004https://conductscience.org/library/papers/15202568PubMed
1735758934Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine.ACS Nano2022https://conductscience.org/library/papers/35758934PubMed
1827726379Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals.Anal Chem2016https://conductscience.org/library/papers/27726379PubMed
193518749The membrane attack complex of complement.Annu Rev Immunol1986https://conductscience.org/library/papers/3518749PubMed
2034891120Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice.Biomed Pharmacother2022https://conductscience.org/library/papers/34891120PubMed

See all 68 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42345324In-Depth Characterization of PEGylated Liposomes: Using AF4 and HPLC-CAD in Tandem as a Strategy for Composition Assessment and Postinsertion Optimization.Anal Chem2026https://conductscience.org/library/papers/42345324PubMed
41139912The Distribution of Complement Proteins in Soft and Hard Coronas Impacts Macrophage Uptake of Nanoparticles.Adv Healthc Mater2026https://conductscience.org/library/papers/41139912PubMed
41008206Current Status and Future Prospects on Nanodelivery Systems Targeting the Small Intestine for Absorption of Bioactive Substances.Foods2025https://conductscience.org/library/papers/41008206PubMed
40632862Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors.Sci Adv2025https://conductscience.org/library/papers/40632862PubMed
40264371PEGylation technology: addressing concerns, moving forward.Drug Deliv2025https://conductscience.org/library/papers/40264371PubMed
39852793Regulating Immune Responses Induced by PEGylated Messenger RNA-Lipid Nanoparticle Vaccine.Vaccines (Basel)2024https://conductscience.org/library/papers/39852793PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39119697

GET https://conductscience.org/api/papers/v1/39119697/references?page=2